A Study for Patients With Relapsing Remitting Multiple Sclerosis

Clinical trial NCT00869986 · COMPLETED

Trial details

NCT number: NCT00869986
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2006-11-01
Primary completion: 2009-09-01
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.